Akèy › Amiloidoz › Tennessee › Nashville
Etid klinik pou Amiloidoz nan Nashville, TN
5 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Ap rekriteEtid obsèvasyon
- Research Site, Nashville
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Ap rekriteFaz 3
- Clinical Trial Site, Nashville
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Ap rekriteFaz 1/2
- Vanderbilt Ingram Cancer Center, Nashville
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Ap rekriteFaz 1/2
- Research Site, Nashville
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Ap rekriteFaz 1/2
- Vanderbilt University Medical Center. /ID# 273510, Nashville
Etid Amiloidoz nan lòt vil
- Boston, MA11 etid
- New York City, NY10 etid
- Rochester, MN10 etid
- Dallas, TX9 etid
- Philadelphia, PA7 etid
- Houston, TX6 etid
- Durham, NC6 etid
- Baltimore, MD6 etid
- St. Louis, MO6 etid
- Portland, OR6 etid
- Chicago, IL5 etid
- Cleveland, OH5 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.